eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

 
3/2009
vol. 5
 
Share:
Share:
more
 
 
abstract:

Clinical research
Captopril and losartan modify mitogen-induced proliferative response and expression of some differentiation antigents on peripheral blood mononuclear cells in chronic uraemic patients

Piotr Bartnicki
,
Ewa Majewska
,
Radosław Wilk
,
Zbigniew Baj
,
Jacek Rysz

Arch Med Sci 2009; 5, 3: 401-407
Online publish date: 2009/10/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction: The renin-angiotensin system plays an important role in immune mechanisms. It is still insufficiently known whether angiotensin converting enzyme inhibitors and selective angiotensin type 1-receptor antagonists interfere with immune cells. That led us to investigate whether angiotensin converting enzyme inhibitor – captopril and selective angiotensin type 1-receptor antagonist – losartan modify some functions of immune cells in chronic uraemic patients and healthy subjects.
Material and methods: In 15 chronic uraemic patients on regular hemodialysis treatment and 15 control subjects we investigated in vitro mitogen induced proliferative response of peripheral blood mononuclear cells and expression of some lymphocyte differentiation antigens in the presence of captopril and losartan, equal to their therapeutic concentrations. As mitogen was used phytohemagglutinin P and phorbol myristate acetate.
Results: In our in vitro experiment captopril and losartan, in investigated concentrations, depressed mitogen induced proliferative response of peripheral blood mononuclear cells and lowered expression and numbers of some lymphocyte differentiation antigens in chronic uraemic patients and control subjects.
Conclusions: Our in vitro results seem to indicate that captopril and losartan interfere with immune cells and depress some functions of immune cells in chronic uremic patients and healthy subjects. It is very difficult at present to establish significance of these in vitro immunosuppresive effects of captopril and losartan reflects their in vivo action. Its significance for clinical implications necessitates further extensive studies.
keywords:

captopril, losaratan, chronic uraemia, blood mononuclear cells, proliferative response, differentiation antigens

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe